Cascadian Therapeutics Inc (CASC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2017 | 09-2017 | 06-2017 | 03-2017 | 12-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 16,777 | 12,739 | 12,915 | 35,674 | 13,721 |
| Marketable Securities | 76,500 | 89,259 | 109,814 | 90,215 | 49,084 |
| Receivables | 344 | 333 | 333 | 216 | 238 |
| TOTAL | $94,839 | $103,553 | $123,863 | $127,815 | $64,454 |
| Non-Current Assets | |||||
| PPE Net | 656 | 1,395 | 1,544 | 1,670 | 1,402 |
| Investments And Advances | 7,711 | 10,981 | 2,686 | 10,244 | 0 |
| Intangibles | 16,659 | 16,659 | 16,659 | 16,659 | 16,659 |
| Other Non-Current Assets | 960 | 799 | 760 | 784 | 750 |
| TOTAL | $25,986 | $29,834 | $21,649 | $29,357 | $18,811 |
| Total Assets | $120,825 | $133,387 | $145,512 | $157,172 | $83,265 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,246 | 619 | 297 | 1,028 | 824 |
| Accrued Expenses | 9,158 | 7,721 | 6,845 | 4,091 | 7,597 |
| Other current liabilities | 355 | 393 | 392 | 262 | 352 |
| TOTAL | $11,759 | $8,733 | $7,534 | $5,381 | $8,773 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 30 | 38 | 70 | 102 | 135 |
| TOTAL | $30 | $38 | $70 | $102 | $135 |
| Total Liabilities | $11,789 | $8,771 | $7,604 | $5,483 | $8,908 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 55,317 | 50,560 | 50,553 | 49,236 | 49,222 |
| Common Shares | 353,852 | 353,852 | 353,852 | 353,852 | 353,849 |
| Retained earnings | -629,268 | -612,506 | -598,445 | -583,736 | -572,334 |
| Other shareholders' equity | -5,185 | -5,092 | -5,114 | -5,092 | -5,080 |
| TOTAL | $109,036 | $124,616 | $137,908 | $151,689 | $74,357 |
| Total Liabilities And Equity | $120,825 | $133,387 | $145,512 | $157,172 | $83,265 |